Bioleaders Corporation (142760) — Free Cash Flow Generation Index

Latest as of September 2024: -17.47x

Bioleaders Corporation (142760) has a Free Cash Flow Generation Index of -17.47x as of September 2024. Free cash flow of ₩-866.03 Million represents -17% of operating cash flow (₩49.56 Million). Explore capital reinvestment ratio of Bioleaders Corporation to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

-17.47x
Free Cash Flow / Operating CF

Free Cash Flow

₩-866.03 Million
KRW

Operating Cash Flow

₩49.56 Million
KRW

Capital Expenditures

₩1.04 Billion
KRW

Bioleaders Corporation Free Cash Flow Generation Index (2023–2023)

Historical FCF Generation Index trend for Bioleaders Corporation across 1 annual periods. For the full cash flow conversion analysis, see Bioleaders Corporation (142760) cash flow conversion.

Annual Free Cash Flow Generation for Bioleaders Corporation (2023–2023)

Year-by-year Free Cash Flow Generation Index for Bioleaders Corporation. Check 142760 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2023 0.94x ₩5.80 Billion ₩6.18 Billion ₩378.81 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).